The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

17 Apr 2018 07:00

RNS Number : 0910L
Mercia Technologies PLC
17 April 2018
 

RNS

17 April 2018

 

Mercia Technologies PLC("Mercia" or the "Group")

Board Change

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions, announces that Matthew Mead, Mercia's Chief Investment Officer, has notified the Group of his desire to step down from the Board and from his role as Chief Investment Officer with immediate effect, in order to pursue a portfolio advisory career. Following a handover period, Matt will remain working part-time with the Group as a Venture Partner, sitting on several investment panels for Mercia's managed funds. Matt will ensure an orderly handover of responsibilities to Mercia's current Head of Technology Investments, Julian Viggars, who is promoted to Chief Investment Officer and joins Mercia's Board with effect from today.

Julian joined Enterprise Ventures Group Limited ("Enterprise Ventures") in 2004 and has over 20 years of venture capital experience, including the successful listings of companies such as Blue Prism Group plc and Xeros Technology Group plc. Julian joined Mercia through the 2016 acquisition of Enterprise Ventures and has worked closely with Matt in leading the combined investment teams and managing the pipeline of Mercia's future 'Emerging Stars'. Alongside his deep knowledge of the technology sector, Julian is Fund Manager for the Northern Powerhouse Investment Fund ("NPIF"), the RisingStars Growth Funds and the Finance Yorkshire Seedcorn Fund, which together include the successful quoted businesses Blue Prism Group plc, Xeros Technology Group plc, and Optibiotix Health plc, amongst others.

Julian Viggars holds the following Ordinary shares and options:

PDMR

Total number of Ordinary shares

Number of options over Ordinary shares

Julian Viggars

424,325*

400,000

*Including 75,000 Ordinary shares held by Mrs Emma Viggars

Further information on Julian, as required by Schedule 2 (g) of the AIM Rules for Companies, is included within the appendix to this announcement.

 

Dr Mark Payton, CEO of Mercia Technologies PLC, said:

 

"I'd like to thank Matt for his work during the last three years. Working with Julian, he has provided valuable leadership in combining both Mercia's existing and Enterprise Ventures' investment teams, as well as offering important insight across all four of our technology sectors, including leading Mercia's recent successful exit from Science Warehouse. We look forward to continuing to work with him in his future advisory role as a Venture Partner.

 

"We are pleased to welcome Julian Viggars onto Mercia's Board as Chief Investment Officer and believe that his significant technology investment experience and successful exit track record will undoubtedly benefit the Group as it enters its next phase of value creation and realisations."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatech.co.uk

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys, Camilla Hume (NOMAD and Joint Broker)

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (Joint Broker)

Buchanan

+44 (0)20 7466 5000

Bobby Morse, Chris Lane, Stephanie Watson

www.buchanan.uk.com

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third party funds (now with circa £350.0million under management following recent mandate wins) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £46.0million directly across its portfolio of 'Emerging Stars'.

 

Appendix

Pursuant to Schedule 2 (g) of the AIM Rules for Companies, Julian George Viggars (aged 50) has held the following directorships or partnerships in the past five years:

Current

Enterprise Ventures Limited

Enterprise Ventures (General Partner NPIF YHTV Equity) Limited

Enterprise Ventures (General Partner NE Venture) Limited

Enterprise Ventures (General Partner Midlands POC) Limited

Enterprise Ventures (General Partner Midlands Equity) Limited

Mercia Fund Management (Nominees) Limited

Mercia Fund Management Limited

Mercia Growth Nominees 6 Limited

Mercia Growth Nominees 5 Limited

Xeros Technology Group Plc

Xeros Limited

Secondary Partners LLP

Enterprise Ventures (General Partner Risingstars) Limited

Enterprise Ventures (General Partner FY Seedcorn) Limited

Enterprise Ventures (General Partner Risingstars II) Limited

Enterprise Ventures (General Partner NW Venture) Limited

Electro-Medical Limited

Blackley Holdings Limited

Blackley (2010) Limited

Previous

Platform Diagnostics Limited

Ffrees Family Finance LimitedPeckforton Pharmaceuticals LimitedCarlton Manufacturing LtdInertius Limited (dissolved)

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKADPABKDPQD
Date   Source Headline
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares
15th Feb 20249:31 amRNSTransaction in Own Shares
9th Feb 20249:46 amRNSTransaction in Own Shares
8th Feb 20249:41 amRNSTransaction in Own Shares
7th Feb 20249:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.